Radiation Therapy News and Research

RSS
Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.
Study challenges the use of biochemical recurrence as prostate cancer predictor

Study challenges the use of biochemical recurrence as prostate cancer predictor

Some early-stage, low-risk breast cancer patients may not need radiotherapy after surgery

Some early-stage, low-risk breast cancer patients may not need radiotherapy after surgery

Two new subtypes of HPV+ head and neck cancers identified

Two new subtypes of HPV+ head and neck cancers identified

Researchers discover potential new treatment for rhabdomyosarcoma

Researchers discover potential new treatment for rhabdomyosarcoma

New technique can make radiation therapy safer for patients with prostate cancer

New technique can make radiation therapy safer for patients with prostate cancer

Breast cancer treatment linked to faster biological aging

Breast cancer treatment linked to faster biological aging

Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

Cetuximab plus radiotherapy effective in treating locally advanced cutaneous squamous cell cancer

New technique shows potential to generically treat several kinds of cancer

New technique shows potential to generically treat several kinds of cancer

UTHSC team poised to make a real-world impact on vulnerable cancer patients

UTHSC team poised to make a real-world impact on vulnerable cancer patients

Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer

Adagrasib shows promise for the treatment of patients with KRAS G12C-mutated non-small cell lung cancer

No improvement in freedom from progression rates for patients: Study

No improvement in freedom from progression rates for patients: Study

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

Study suggests possible new treatment option for people with slow-growing but deadly brain tumor

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

SWOG Cancer Research Network clinical trial reveals potential new therapy for Stage 3 or 4 classic Hodgkin lymphoma

Novel treatment targets against natural killer/T-cell lymphoma identified

Novel treatment targets against natural killer/T-cell lymphoma identified

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Telephone-based weight loss program can help patients with breast cancer to reduce their weight

Telephone-based weight loss program can help patients with breast cancer to reduce their weight

Study could help understand why limiting sugary foods can ease symptoms for IBD patients

Study could help understand why limiting sugary foods can ease symptoms for IBD patients

Study examines safety and efficacy of made-to-fade tattoos for medical markings

Study examines safety and efficacy of made-to-fade tattoos for medical markings

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Combination approach is safe, improves survival outcomes in a subset of glioblastoma patients

Patient-derived head and neck cancer organoids could aid the discovery of novel therapies

Patient-derived head and neck cancer organoids could aid the discovery of novel therapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.